|
國藥科技股份有限公司, 08156.HK - 綜合損益表 |
2023-06 |
2022-06 |
2021-06 |
2020-06 |
2019-06 |
2018-06 |
2017-06 |
2016-06 |
2015-06 |
2014-06 |
2013-06 |
2012-06 |
2011-06 |
2010-06 |
2009-06 |
2008-06 |
2007-06 |
2006-06 |
2005-06 |
營業額 |
42,839 |
40,985 |
77,813 |
165,934 |
43,503 |
25,347 |
26,359 |
34,657 |
123,736 |
95,786 |
39,098 |
104,838 |
112,734 |
97,510 |
66,787 |
78,292 |
88,246 |
81,608 |
189,131 |
經營溢利 |
-8,755 |
-72,116 |
-80,818 |
-32,880 |
-47,938 |
-60,818 |
-170,759 |
-202,932 |
31,798 |
31,818 |
-34,923 |
-31,933 |
-17,416 |
-36,738 |
-49,354 |
-93,325 |
-132,977 |
-70,475 |
22,044 |
非經營/ 特殊項目 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-88,507 |
-993,309 |
25,629 |
-13,347 |
30,635 |
0 |
0 |
聯營公司 |
186 |
-153 |
3,588 |
558 |
0 |
0 |
0 |
-490 |
-905 |
-2,881 |
3,250 |
0 |
0 |
0 |
0 |
0 |
0 |
18,830 |
17,653 |
除稅前經營溢利 |
-11,407 |
-94,158 |
-111,064 |
-165,380 |
-47,938 |
-73,399 |
-184,075 |
-215,410 |
20,173 |
19,184 |
-41,796 |
-1,104,915 |
-105,923 |
-1,030,047 |
-23,725 |
-106,672 |
-102,342 |
-51,645 |
39,697 |
稅項 |
-1,307 |
-387 |
-558 |
-1,390 |
-2,312 |
-1,814 |
-2,835 |
-1,568 |
2,329 |
6,038 |
672 |
3,036 |
4,317 |
2,280 |
1,149 |
2,306 |
1,411 |
6,717 |
9,086 |
少數股東權益 |
535 |
-5,773 |
-4,166 |
-2,915 |
1,170 |
-10,551 |
-6,213 |
-7,064 |
-1,263 |
-1,741 |
-847 |
-446 |
6,725 |
39,492 |
5,377 |
3,391 |
-30,960 |
-18,454 |
-1,074 |
股東應占溢利 |
-10,635 |
-87,998 |
-106,340 |
-161,075 |
-46,796 |
-61,034 |
-175,027 |
-206,778 |
19,107 |
14,887 |
-41,621 |
-1,107,505 |
61,439 |
-1,047,777 |
-100,643 |
-116,405 |
-72,521 |
-39,908 |
31,685 |
貨幣 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
單位 |
千 |
千 |
千 |
千 |
千 |
千 |
千 |
千 |
主要項目 |
折舊 |
2,007 |
2,426 |
10,454 |
9,269 |
11,102 |
12,782 |
9,463 |
7,513 |
3,848 |
6,120 |
5,067 |
15,642 |
15,932 |
17,900 |
34,343 |
28,837 |
10,670 |
1,428 |
1,384 |
利息 |
8,571 |
16,410 |
14,546 |
18,154 |
11,950 |
12,581 |
13,316 |
11,988 |
10,720 |
9,753 |
10,123 |
10,315 |
7,340 |
37,165 |
66,112 |
41,874 |
24,537 |
3,005 |
1,849 |
利息撥作發展資本 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
處置/重估固定資產 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
稅率(%) |
11.46 |
0.41 |
0.5 |
0.84 |
4.82 |
2.47 |
1.54 |
0.73 |
11.55 |
31.47 |
-1.61 |
|
|
|
|
|
|
|
22.89 |
營業額增長(%) |
4.52 |
-47.33 |
-53.11 |
281.43 |
71.63 |
-3.84 |
-23.94 |
-71.99 |
29.18 |
144.99 |
-62.71 |
-7.0 |
15.61 |
-37.39 |
-14.69 |
57.54 |
12.07 |
-56.85 |
-1.99 |
股東應占溢利增長(%) |
87.91 |
17.25 |
33.98 |
-244.21 |
23.33 |
65.13 |
15.36 |
0.0 |
28.35 |
-135.77 |
-96.24 |
|
|
|
|
|
|
|
9.21 |
核數師意見 |
2 |
2 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
1 |
說明:1代表無保留意見;2代表保留意見;3代表修改意見
|
|